Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.

Biotechnology

Inflection Biosciences

Inflection Biosciences' headquarters in Blackrock, Ireland

Darren Cunningham

Michael O'Neill

Gerry McGettigan

Gemma Carroll

Tess Barker

John Lynch

Josep Tabernero

Martin Buckland

Conor Mallaghan

Funda Meric Bernstam

Martin Dreyling

Micheall O'Neill

Arthur Pratt

Andrew Leishman

Patrick Walsh

Regulatory Affairs

Scientific Research and Development

Inflection Biosciences

Org chart

Board & advisors

Teams

Regulatory Affairs

Scientific Research and Development

Offices

Similar companies